This page provides detailed compound profiles for the four healing peptides most commonly used in the optimization community. For stack protocols and how to combine these compounds for specific injury types, see our Injury Repair Stack guide. For broader context on how peptides work, see Peptides Explained. This page focuses on each compound individually: what it is, how it works, what the research says, how to dose it, and what its limitations are.
BPC-157 (Body Protection Compound)
BPC-157 is a synthetic 15-amino-acid peptide derived from a protective protein found in human gastric juice. It is the most widely studied and used healing peptide in the optimization community, with over 100 published research papers spanning tendon healing, muscle repair, bone healing, gut protection, neuroprotection, and cardiovascular effects.
Key Mechanisms
- Angiogenesis: Increases VEGF (vascular endothelial growth factor) expression, promoting new blood vessel formation at injury sites
- Growth factor modulation: Upregulates EGF, FGF, and HGF, critical growth factors for tissue repair
- Nitric oxide regulation: Modulates the NO system for blood flow regulation and tissue protection
- Tendon-to-bone healing: Improves healing at tendon-bone junctions, particularly relevant for surgical repairs and sports injuries
- GI protection: Protects against NSAID-induced gut damage, gastric ulcers, and inflammatory bowel conditions
- Neuroprotection: Emerging evidence for effects on dopaminergic pathways and peripheral nerve healing
Dosing
- Standard dose: 250-500mcg per injection, 1-2 times daily
- Administration: Subcutaneous injection. Can be injected near the injury site (local) or in the abdomen (systemic). Both routes work; local injection may provide faster localized effects
- Duration: 4-12 weeks depending on injury severity
- Oral: Available in oral capsule form for gut-specific applications. Typical oral dose: 250-500mcg 1-2 times daily on an empty stomach
Research Quality
BPC-157 has an extensive body of animal research (primarily rodent models) showing consistent positive results across multiple tissue types and injury models. The consistency across different injury types and research groups lends credibility to the mechanistic findings. However, there are no published large-scale randomized controlled trials in humans for musculoskeletal indications. Human evidence is primarily clinical observations and case reports from practicing physicians. The evidence base is strong enough to support informed use but not strong enough to make definitive clinical claims.
BPC-157 Evidence Summary
TB-500 (Thymosin Beta-4 Synthetic Fragment)
TB-500 is a synthetic version of Thymosin Beta-4, a 43-amino-acid peptide naturally present in virtually all human and animal cells. Thymosin Beta-4 is one of the most abundant intracellular peptides in the body, with particularly high concentrations in blood platelets, wound fluid, and sites of tissue damage.
Key Mechanisms
- Actin upregulation: TB-500's primary mechanism. Actin is the structural protein that forms the cytoskeleton of every cell. By upregulating actin, TB-500 promotes cell migration to injury sites, cell proliferation, and organized tissue formation
- Anti-inflammatory: Reduces inflammatory cytokines and shifts the inflammatory response toward repair rather than chronic inflammation
- Angiogenesis: Promotes new blood vessel formation through pathways different from BPC-157, which is why the two stack well together
- Stem cell support: Supports maturation and differentiation of stem cells, enhancing regenerative capacity
- Cardiac repair: Significant research interest in Thymosin Beta-4 for cardiac tissue repair following myocardial infarction
- Hair follicle stimulation: Stimulates hair follicle stem cells, with some users reporting improved hair quality as a secondary benefit
Dosing
- Loading dose (weeks 1-4): 2-2.5mg via subcutaneous injection, twice weekly
- Maintenance dose (weeks 5+): 2mg once weekly
- Administration: Subcutaneous injection, typically abdominal. TB-500 is a systemic compound so injection site relative to injury is less critical than with BPC-157
- Duration: 8-12 weeks for significant injuries
Pro Tip
GHK-Cu (Copper Peptide)
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide first identified in human blood plasma in 1973. It is found in blood, saliva, and urine, and its levels decline dramatically with age: by age 60, plasma levels are roughly one-third of age-20 levels. This natural decline correlates with the visible and measurable signs of aging.
Key Mechanisms
- Gene expression regulation: GHK-Cu influences over 4,000 genes, systematically upregulating repair/regenerative genes and downregulating inflammatory/destructive genes
- Collagen synthesis: Stimulates collagen types I, III, and V, supporting skin, tendon, and vascular health
- Anti-inflammatory: Reduces NFkB activation and pro-inflammatory cytokines (IL-6, TNF-alpha)
- Antioxidant defense: Upregulates endogenous antioxidant enzymes (superoxide dismutase, etc.)
- Wound healing: Accelerates healing of skin, bone, stomach, and liver tissue
- Stem cell attraction: Attracts repair stem cells to sites of tissue damage
Dosing and Administration
- Subcutaneous injection: 1-2mg daily for systemic effects. Cycle: 20-30 days on, equal time off
- Topical application: Available as creams and serums (0.1-1% concentration) for skin-specific applications: anti-aging, wound healing, post-procedure skin recovery, hair growth
- Duration: Subcutaneous cycles of 20-30 days, 2-4 cycles per year. Topical can be used continuously
Research Quality
GHK-Cu has a strong research base for topical/skin applications, with multiple studies confirming its collagen-stimulating and wound-healing properties. The gene expression research (4,000+ genes) is from well-designed genomic studies. The injectable/systemic evidence is less extensive than the topical data but supported by the breadth of gene expression findings and animal studies. It is well-studied for anti-aging and skin health, with a growing evidence base for systemic use.
KPV (Alpha-MSH Fragment)
KPV is a tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte stimulating hormone (alpha-MSH). Unlike the full alpha-MSH molecule, KPV does not cause skin tanning or the melanocortin receptor effects associated with peptides like Melanotan. Instead, it isolates the potent anti-inflammatory properties of the alpha-MSH molecule.
Key Mechanisms
- Anti-inflammatory: KPV's primary mechanism. It enters cells and directly interferes with inflammatory signaling cascades, particularly the NFkB pathway
- Intestinal inflammation reduction: Particularly relevant for inflammatory bowel conditions. KPV has shown the ability to reduce colonic inflammation in animal models of IBD
- Antimicrobial: KPV has demonstrated antimicrobial activity against certain bacteria, fungi, and Candida species
- Immune modulation: Modulates immune cell activity without broadly suppressing immune function. This is different from corticosteroids, which suppress the entire immune response
Dosing
- Subcutaneous injection: 200-500mcg per day for systemic anti-inflammatory effects
- Oral: Available in capsule form for gut-specific applications, though bioavailability through the GI tract is debated
- Duration: 4-8 weeks, or as directed by a provider for specific inflammatory conditions
KPV Evidence Limitations
Choosing the Right Healing Peptide
- Tendon/ligament/muscle injury: BPC-157 (primary) + TB-500 (secondary). See the Injury Repair Stack
- Post-surgical recovery: BPC-157 + TB-500 + GH secretagogue. The most comprehensive healing protocol
- Gut health / GI issues: BPC-157 (oral or injectable) and/or KPV for inflammatory bowel conditions
- Skin aging / wound healing: GHK-Cu (topical for skin, injectable for systemic). Can combine with BPC-157
- Chronic inflammation: KPV for targeted anti-inflammatory effects. GHK-Cu for gene-level anti-inflammatory reprogramming
- Longevity / general anti-aging: GHK-Cu (see the Longevity Stack)
The Bottom Line
Healing peptides represent one of the most promising areas in the optimization space because they work through fundamental biological mechanisms that are well-understood at the molecular level. BPC-157 and TB-500 are the workhorses for musculoskeletal healing with complementary mechanisms that make them ideal combination partners. GHK-Cu offers a unique gene-expression-level approach to tissue repair and anti-aging. KPV provides targeted anti-inflammatory support that is particularly relevant for gut health. All four are generally well-tolerated with favorable safety profiles, though the evidence base varies by compound from strong (BPC-157) to still emerging (KPV).